LINC01712

Across TCGA pan-cancer cohorts, LINC01712 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated LINC01712 data layer compared with 1 for mutation status.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher LINC01712 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01712 expression acts as an unfavorable survival marker.

OV, LUSC, and SKCM are the cancer types where LINC01712 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	III,IV	0.201	0.325	.010	48	view →
LUSC	DFS	Tertile	III,IV	0.010	0.754	<.001	45	view →
SKCM	DFS	Tertile	II,III,IV	0.036	0.683	<.001	45	view →
UCEC	DFS	Tertile	IV	0.206	0.704	.033	24	view →
BRCA	DFS	Tertile	II,III,IV	0.418	0.520	.020	18	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	18	view →
KIRC	DFS	Tertile	All	0.235	0.632	.037	12	view →
THCA	OS	Tertile	II,III,IV	0.240	0.830	.002	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

LINC01712–OV (OS)

Open the OV breakdown →